Therapeutic monoclonal antibodies for multiple myeloma: an update and future perspectives [0.03%]
多发性骨髓瘤的治疗单克隆抗体：最新研究及未来展望
Jing Yang,Qing Yi
Jing Yang
Multiple myeloma (MM) still remains incurable in most of the patients. Despite of treatments with high-dose chemotherapy, stem cell transplantation and other novel therapies, most patients will become refractory to the therapies and relapse...